Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Clinical trial NCT06388135 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06388135
- Sponsor
- Yang Jianjun, PhD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-05-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.